Home › NCT03511586
Total Shoulder Arthroplasty Multi-Center Registry
RecruitingObservational study
Who can join
Ages 18 to 100 · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Patient voluntarily consents to participate in the study and has the mental and physical ability to participate in the study, fill out subjective questionnaires, return for follow-up visits, and comply with prescribed post-operative physical therapy. 2. Patient is between the ages of 18 and 100 years. 3. The patient has a planned primary or revision implantation of an anatomic (hemi-arthroplasty or total arthroplasty) or a reverse shoulder prosthesis system manufactured by Arthrex. 4. Patient has a standard of care preoperative CT taken within 6 months that has been submitted for Arthrex VIP (Virtual Implant Positioning) planning (not required for acute humeral fractures). Exclusion Criteria 1\. Patient has known intentions, obligations, or co-morbidity that would inhibit them from participating in the study.
About the study
The objective of the study is a multi-center prospective registry to collect clinical outcomes of anatomic and reverse total shoulder arthroplasty.
Sponsor: Arthrex, Inc. · Participants: 2,500 · Started: Jul 28, 2015
Contact the study team
- Kelly Ganz, BA, CCRC · Phone: 1 (800) 933-7001
- Alicia Ruiz, MS, CCRP, CCRA · Phone: 1 (800) 933-7001
Official record on ClinicalTrials.gov — NCT03511586
Locations in the U.S.
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.